» Articles » PMID: 28314877

Fully Automated VMAT Treatment Planning for Advanced-stage NSCLC Patients

Overview
Specialties Oncology
Radiology
Date 2017 Mar 19
PMID 28314877
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To develop a fully automated procedure for multicriterial volumetric modulated arc therapy (VMAT) treatment planning (autoVMAT) for stage III/IV non-small cell lung cancer (NSCLC) patients treated with curative intent.

Materials And Methods: After configuring the developed autoVMAT system for NSCLC, autoVMAT plans were compared with manually generated clinically delivered intensity-modulated radiotherapy (IMRT) plans for 41 patients. AutoVMAT plans were also compared to manually generated VMAT plans in the absence of time pressure. For 16 patients with reduced planning target volume (PTV) dose prescription in the clinical IMRT plan (to avoid violation of organs at risk tolerances), the potential for dose escalation with autoVMAT was explored.

Results: Two physicians evaluated 35/41 autoVMAT plans (85%) as clinically acceptable. Compared to the manually generated IMRT plans, autoVMAT plans showed statistically significant improved PTV coverage (V increased by 1.1% ± 1.1%), higher dose conformity (R reduced by 12.2% ± 12.7%), and reduced mean lung, heart, and esophagus doses (reductions of 0.9 Gy ± 1.0 Gy, 1.5 Gy ± 1.8 Gy, 3.6 Gy ± 2.8 Gy, respectively, all p < 0.001). To render the six remaining autoVMAT plans clinically acceptable, a dosimetrist needed less than 10 min hands-on time for fine-tuning. AutoVMAT plans were also considered equivalent or better than manually optimized VMAT plans. For 6/16 patients, autoVMAT allowed tumor dose escalation of 5-10 Gy.

Conclusion: Clinically deliverable, high-quality autoVMAT plans can be generated fully automatically for the vast majority of advanced-stage NSCLC patients. For a subset of patients, autoVMAT allowed for tumor dose escalation.

Citing Articles

Fully automated volumetric modulated arc therapy technique for radiation therapy of locally advanced breast cancer.

Marrazzo L, Redapi L, Pellegrini R, Voet P, Meattini I, Arilli C Radiat Oncol. 2023; 18(1):176.

PMID: 37904150 PMC: 10617151. DOI: 10.1186/s13014-023-02364-8.


Machine learning in non-small cell lung cancer radiotherapy: A bibliometric analysis.

Zhang J, Zhu H, Wang J, Chen Y, Li Y, Chen X Front Oncol. 2023; 13:1082423.

PMID: 37025583 PMC: 10072228. DOI: 10.3389/fonc.2023.1082423.


Patient selection, inter-fraction plan robustness and reduction of toxicity risk with deep inspiration breath hold in intensity-modulated radiotherapy of locally advanced non-small cell lung cancer.

Fjellanger K, Rossi L, Heijmen B, Pettersen H, Sandvik I, Breedveld S Front Oncol. 2022; 12:966134.

PMID: 36110942 PMC: 9469652. DOI: 10.3389/fonc.2022.966134.


Automated Planning for Prostate Stereotactic Body Radiation Therapy on the 1.5 T MR-Linac.

Naccarato S, Rigo M, Pellegrini R, Voet P, Akhiat H, Gurrera D Adv Radiat Oncol. 2022; 7(3):100865.

PMID: 35198836 PMC: 8850203. DOI: 10.1016/j.adro.2021.100865.


Enhancing Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer Patients with iCE, a Novel System for Automated Multi-Criterial Treatment Planning Including Beam Angle Optimization.

Fjellanger K, Hysing L, Heijmen B, Pettersen H, Sandvik I, Sulen T Cancers (Basel). 2021; 13(22).

PMID: 34830838 PMC: 8616198. DOI: 10.3390/cancers13225683.


References
1.
Sharpe M, Moore K, Orton C . Point/Counterpoint: Within the next ten years treatment planning will become fully automated without the need for human intervention. Med Phys. 2014; 41(12):120601. DOI: 10.1118/1.4894496. View

2.
Sharfo A, Voet P, Breedveld S, Mens J, Hoogeman M, Heijmen B . Comparison of VMAT and IMRT strategies for cervical cancer patients using automated planning. Radiother Oncol. 2015; 114(3):395-401. DOI: 10.1016/j.radonc.2015.02.006. View

3.
Voet P, Dirkx M, Breedveld S, Al-Mamgani A, Incrocci L, Heijmen B . Fully automated volumetric modulated arc therapy plan generation for prostate cancer patients. Int J Radiat Oncol Biol Phys. 2014; 88(5):1175-9. DOI: 10.1016/j.ijrobp.2013.12.046. View

4.
Bezjak A, Rumble R, Rodrigues G, Hope A, Warde P . Intensity-modulated radiotherapy in the treatment of lung cancer. Clin Oncol (R Coll Radiol). 2012; 24(7):508-20. DOI: 10.1016/j.clon.2012.05.007. View

5.
Zhang X, Li X, Quan E, Pan X, Li Y . A methodology for automatic intensity-modulated radiation treatment planning for lung cancer. Phys Med Biol. 2011; 56(13):3873-93. DOI: 10.1088/0031-9155/56/13/009. View